The U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee voted against the approval of the use of oral anticoagulant Xarelto (rivaroxaban) to reduce the risk of thrombotic cardiovascular events in patients with Acute Coronary Syndrome (ACS) in combination with standard antiplatelet therapy. Janssen Research & Development LLC sought approval of rivaroxaban at a proposed dose of 2.5 mg twice daily (BID) for a 90-day treatment duration.

The first commercial implant of Elixir Medical’s CE Mark-approved DESolve Novolimus Eluting Coronary Scaffold was performed in Germany. Elixir’s fully bioresorbable DESolve scaffold for coronary artery disease restores blood flow to the heart like metallic stents and then dissolves, resulting in a functional artery free of a permanent implant.
BioVentrix’s Revivent-TC Ventricular Enhancement System was implanted in a man via Less Invasive Ventricular Enhancement (LIVE) in Prague, Czech Republic. The procedure, which is used to reshape and reduce the left ventricle, was performed on a 64-year-old man suffering from ischemic heart failure.
BeneChill Inc. received the 2014 Frost & Sullivan Award for Technology Innovation Leadership for its RhinoChill intranasal cooling system. BeneChill's RhinoChill is a nasopharyngeal device that can induce and sustain therapeutic hypothermia during active resuscitation after cardiac arrest. The system is noninvasive, time critical and can be used by nonmedical personnel to prevent brain damage associated with cardiac arrest.
syngo.via, Siemens, iPhone, remote image access
airstrip mobile access to ECG
pre-hospital ECG, physio-Control, LifeNet, STEMI alert system

As the world becomes more wired and mobile devices offer instant access to email, apps and the Web, it is only natural this technology is migrating into the healthcare sector, where physicians are seeking workflows similar to what they are familiar with when using their devices during free time. In addition to anywhere access to patient records, mobile devices can enable new functionality, such as critical results communication, mobile radiology image viewing for referring physician access, electrocardiogram (ECG) waveform access for immediate ST segment elevation myocardial infarction (STEMI) or other emergency assessment, and the ability to view completed reports on the go.

Computed Tomography (CT) procedure rates have declined by an average annual 5.5 percent in the United States over the past two years, diverging from a previous decade-long growth trend, according to a survey conducted by IMV Medical Information Division.

The Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics (TCT) 2013 offers many new insights about the latest cardiovascular technologies and treatment techniques. These are my choices for the most innovative new or futuristic technologies highlighted on the show floor or in sessions at TCT 2013.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now